Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MoodElite T-4003-1 is a proprietary botanical extract developed by TCI Co., Ltd., primarily derived from the peel of the banana (*Musa sapientum*). Marketed under the trade name Happy Banana, the extract is standardized for bioactive compounds intended to support emotional well-being, alleviate anxiety, and improve sleep quality. Its mechanism of action is centered on the modulation of the serotonergic and melatonergic pathways, specifically through the upregulation of tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme in serotonin synthesis. By increasing endogenous levels of serotonin and its derivative melatonin, the extract helps regulate mood and circadian rhythms. Clinical evaluation in healthy adults with mild to moderate depressive symptoms (NCT05318456) has demonstrated its potential to improve mood scores and sleep efficiency while reducing stress markers such as cortisol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MoodElite T-4003-1.